This is consistent with our finding that SLE pDCs demonstrated decreased ability to induce CD4+CD25highFoxP3+ T cells, the numbers and function of which are known to be impaired in patients with active SLE70–72. The gene discussed is CD4; the disease is systemic lupus erythematosus.